The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population
Authors:
- Hideaki KobayashiHKHideaki Kobayashi
- Hiroshi UjikeHUHiroshi Ujike
- Nakao IwataNINakao Iwata
- Toshiya InadaTIToshiya Inada
- Mitsuhiko YamadaMYMitsuhiko Yamada
- Yoshimoto SekineYSYoshimoto Sekine
- Naohisa UchimuraNUNaohisa Uchimura
- Masaomi IyoMIMasaomi Iyo
- Norio OzakiNONorio Ozaki
- Masanari ItokawaMIMasanari Itokawa
- Ichiro SoraISIchiro Sora
Open Access
- 30 August 2010
- journal article
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 6 (1) , 50
Abstract
Background: Several lines of evidence suggest that the dopaminergic nervous system contributes to methamphetamine (METH) dependence, and there is increasing evidence of antagonistic interactions between dopamine and adenosine receptors. We therefore hypothesized that variations in the A2A adenosine receptor (ADORA2A) gene modify genetic susceptibility to METH dependence/psychosis.Methods: We first analyzed variations in the exons and exon-intron boundaries of theADORA2Agene in METH dependent/psychotic patients. Then an association analysis between these single nucleotide polymorphisms and METH dependence/psychosis was performed using a total of 171 METH dependent/psychotic patients and 229 controls.Results: We found 6 variations, of which one single nucleotide polymorphism (SNP) was novel. Significant associations were observed between the allelic and genotypic frequencies of the Exon2+751 (rs5751876) SNP and METH dependence/psychosis. These associations were observed especially in females. In the clinical feature analyses, significant associations were observed between the SNP and the patient subgroup using METH alone (i.e., without concomitant use of other substances of abuse).Conclusions: These results suggest that theADORA2Agene could be a vulnerability factor for METH dependence/psychosis, especially in females and/or in patients using only METH.Keywords
This publication has 29 references indexed in Scilit:
- Pharmacotherapy of Methamphetamine Addiction: An UpdateSubstance Abuse, 2008
- Interindividual variation in anxiety response to amphetamine: Possible role for adenosine A2A receptor gene variantsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Study of Association between α‐Synuclein Gene Polymorphism and Methamphetamine Psychosis/DependenceAnnals of the New York Academy of Sciences, 2004
- Gender-specific contribution of the GABAA subunit genes on 5q33 in methamphetamine use disorderThe Pharmacogenomics Journal, 2003
- Association between the glutathione S‐transferase M1 gene deletion and female methamphetamine abusersAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2003
- Association Between A2a Receptor Gene Polymorphisms and Caffeine-Induced AnxietyNeuropsychopharmacology, 2003
- Inactivation of Adenosine A2A Receptors Selectively Attenuates Amphetamine-Induced Behavioral SensitizationNeuropsychopharmacology, 2003
- Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosisThe Pharmacogenomics Journal, 2003
- Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorderJournal of Neural Transmission, 2001
- Human adenosine A2a receptor (A2aAR) gene: systematic mutation screening in patients with schizophreniaJournal of Neural Transmission, 1996